Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Yogev

Showing results (161-170 of 170) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 170 results.
JAMA|February 5, 2000
Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study TeamS A Nachman, K Stanley, R Yogev, et al.
The Pediatric Infectious Disease Journal|June 3, 1999
Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Study Team. AIDS Clinical Trials GroupK McIntosh, E Cooper, J Xu, et al.
Journal of the American College of Cardiology|September 15, 2000
High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edemaA Sharon, I Shpirer, E Kaluski, et al.
The Journal of Pediatrics|October 27, 1998
A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study TeamR E McKinney, G M Johnson, K Stanley, et al.
Clinical Pharmacology and Therapeutics|June 21, 2014
Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescentsD Gonzalez, C Melloni, R Yogev, et al.
The Journal of Infectious Diseases|May 1, 1996
Randomized study of the tolerance and efficacy of high- versus low-dose zidovudine in human immunodeficiency virus-infected children with mild to moderate symptoms (AIDS Clinical Trials Group 128). Pediatric AIDS Clinical Trials GroupM T Brady, N McGrath, P Brouwers, et al.
The Journal of Infectious Diseases|August 18, 2001
Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infantsM S Lee, D P Greenberg, S H Yeh, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218)J S Lambert, J McNamara, S L Katz, et al.
The Journal of Infectious Diseases|October 27, 2001
Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccineE J McFarland, W Borkowsky, T Fenton, et al.
The Journal of Infectious Diseases|November 9, 2000
Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials GroupL M Frenkel, E V Capparelli, W M Dankner, et al.
Pageof 17

Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
JAMA|February 5, 2000
Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study TeamS A Nachman, K Stanley, R Yogev, et al.
The Pediatric Infectious Disease Journal|June 3, 1999
Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Study Team. AIDS Clinical Trials GroupK McIntosh, E Cooper, J Xu, et al.
Journal of the American College of Cardiology|September 15, 2000
High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edemaA Sharon, I Shpirer, E Kaluski, et al.
The Journal of Pediatrics|October 27, 1998
A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study TeamR E McKinney, G M Johnson, K Stanley, et al.
Clinical Pharmacology and Therapeutics|June 21, 2014
Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescentsD Gonzalez, C Melloni, R Yogev, et al.
The Journal of Infectious Diseases|May 1, 1996
Randomized study of the tolerance and efficacy of high- versus low-dose zidovudine in human immunodeficiency virus-infected children with mild to moderate symptoms (AIDS Clinical Trials Group 128). Pediatric AIDS Clinical Trials GroupM T Brady, N McGrath, P Brouwers, et al.
The Journal of Infectious Diseases|August 18, 2001
Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infantsM S Lee, D P Greenberg, S H Yeh, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218)J S Lambert, J McNamara, S L Katz, et al.
The Journal of Infectious Diseases|October 27, 2001
Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccineE J McFarland, W Borkowsky, T Fenton, et al.
The Journal of Infectious Diseases|November 9, 2000
Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials GroupL M Frenkel, E V Capparelli, W M Dankner, et al.
Pageof 17